Unlike IHC studies on ACKR4 protein, which are conducted solely on pathological tissue, paired analysis of gene expression showed the ACKR4 downregulation to be less marked in more dedifferentiated tumors and in patients with lymph node metastasis. Here, ACKR4 is linked to metastatic malignant neoplasm in the lymph nodes.